Randomized, dose-ranging phase II trial of nivolumab for metastatic renal cell carcinoma (MRCC) Meeting Abstract
| Authors: | Motzer, R. J.; Rini, B. I.; McDermott, D. F.; Redman, B.; Kuzel, T.; Harrison, M. R.; Vaishampayan, U. N.; Drabkin, H.; George, S.; Logan, T.; Margolin, K.; Plimack, E. R.; Waxman, I.; Lambert, A.; Hammers, H. |
| Abstract Title: | Randomized, dose-ranging phase II trial of nivolumab for metastatic renal cell carcinoma (MRCC) |
| Meeting Title: | 39th ESMO Congress (ESMO 2014) |
| Journal Title: | Annals of Oncology |
| Volume: | 25 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2014 Sep 26-30 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2014-09-01 |
| Start Page: | iv281 |
| Language: | English |
| ACCESSION: | WOS:000346901000252 |
| DOI: | 10.1093/annonc/mdu337.3 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 810O -- Source: Wos |
